Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
NCT07003451 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-08-28
Summary
\- Assess Krebs von den Lungen-6 (KL-6) and Calprotectin as novel biomarkers for diagnosis of ILD among Rheumatoid arthritis patients
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Calprotectin Level
Measurement of calprotectin level to presence and severity of ILD asessed via Warrick's score
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
waleed gamal elddin, ass. prof · Assiut University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-06-01
Countries
- Egypt
Study Locations
More Related Trials
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
YKL -40 as New Biomarker in COVID -19 Patients
NCT05137509 ·Status: UNKNOWN
-
Renal Manifestations of IBD
NCT04301297 ·Status: UNKNOWN
-
The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
NCT02493101 ·Status: COMPLETED
-
Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
NCT03740685 ·Status: UNKNOWN
-
Patterns and Outcome of Autoimmune Related Liver Disease
NCT03898414 ·Status: COMPLETED
-
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
NCT07062523 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Neutrophil/Lymphocyte Ratio in Acute Pancreatitis
NCT05859633 ·Status: UNKNOWN
-
Prospective Studies on Immunopathogenesis of Liver Fibrosis
NCT04943978 ·Status: RECRUITING
-
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital
NCT06601361 ·Status: NOT_YET_RECRUITING
-
Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta
NCT04945811 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
NCT01063309 ·Status: COMPLETED
-
H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid Arthritis
NCT06586567 ·Status: NOT_YET_RECRUITING
-
Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
NCT00001351 ·Status: ENROLLING_BY_INVITATION
-
Discrimination of DILI and AIH by Artificial Intelligence
NCT05532345 ·Status: COMPLETED
-
New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies
NCT04377867 ·Status: UNKNOWN
-
Identification of New Markers in the Hypereosinophilic Syndrome
NCT01713504 ·Status: COMPLETED ·Phase: NA
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
NCT00499434 ·Status: UNKNOWN
-
Study of New Biological Markers for Prediction of Severe Acute Pancreatitis
NCT00786591 ·Status: COMPLETED
-
Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients
NCT03587714 ·Status: COMPLETED
-
Imaging Biomarkers in Crohn's Associated Spondyloarthritis
NCT02709694 ·Status: COMPLETED
-
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
NCT03841318 ·Status: COMPLETED ·Phase: NA
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED